T11	Exp 119 185	the tumor necrosis factor/nerve growth factor receptor superfamily
T12	Exp 203 205	we
T13	Exp 211 215	that
T14	Exp 310 355	the agonistic anti-CD30 monoclonal antibodies
T15	Exp 190 201	this report
T16	Exp 571 573	it
T17	Exp 505 515	The effect
T18	Exp 519 526	the mAb
T19	Exp 793 803	the type 0
T20	Exp 864 874	the extent
T21	Exp 930 944	the proportion
T22	Exp 993 1017	the NF-kappa B complexes
T23	Exp 1157 1168	our results
T24	Exp 1181 1185	that
T25	Exp 1248 1281	the short-term cellular responses
R2	Coref Anaphora:T16 Antecedent:T17
T1	Protein 0 4	CD30
T2	Protein 80 84	CD30
T3	Protein 292 296	CD30
T4	Protein 329 333	CD30
T5	Protein 878 882	CD30
T6	Protein 948 952	CD30
T7	Protein 1036 1040	CD30
T8	Protein 1074 1089	p50 NF-kappa B1
T9	Protein 1091 1099	p65 RelA
T10	Protein 1301 1305	CD30
